The confusing response to COVID-19 in the U.S. resulted from decisions by President Donald Trump and his allies to politicize the pandemic by associating it with his own fate in office, according to a new book by a Cornell author.
According to new Cornell research, people are more likely to accept the COVID-19 booster the more effective it is, if there are cash incentives and if it is made by Moderna or Pfizer.
New research offers insight as to why individuals who inherit a mutation in one copy of the BRCA1 gene often develop mutations in their remaining normal copy of the BRCA1 gene, setting the stage for tumors to develop.
A new Cornell research project aims to gain a better understanding of how populations of microbes interact on surface environments, such as human skin, where their dynamics are not fully understood.
The latest episode of “All Things Equal” features an interview with Samantha Hillson of the Tompkins County Health Department, on COVID-19 vaccination options and efforts in our local community.
The key to understanding how the most aggressive lymphomas arise and resist current therapies may lie in mutations that disrupt a critical natural selection process among antibody-producing B cells, according to a multi-institutional preclinical study led by Weill Cornell Medicine investigators.
By analyzing key enzymes in a new way, an international team led by researchers at Weill Cornell Medicine has discovered how a well-known signaling molecule can either stimulate or suppress tumor growth depending on where it’s produced.
A study of more than 11,000 adolescents found that taxes on soda reduce consumption by boys but not girls, according to new research collaborated on by economics professor John Cawley.
Multiple types of beta cells produce insulin in the pancreas, helping to balance blood sugar levels. Losing a particularly productive type of beta cell may contribute to the development of diabetes, according to a new study by Weill Cornell Medicine investigators.